Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.

Brains are constantly flooded with sensory information that needs to be filtered at the pre-attentional level and integrated into endogenous activity in order to allow for detection of salient information and an appropriate behavioral response. People with Autism Spectrum Disorder (ASD) or Fragile X Syndrome (FXS) are often over- or under-reactive to stimulation, leading to a wide range of behavioral symptoms. This altered sensitivity may be caused by disrupted sensory processing, signal integration and/or gating, and is often being neglected. Here, we review translational experimental approaches that are used to investigate sensory processing in humans with ASD and FXS, and in relevant rodent models. This includes electroencephalographic measurement of event related potentials, neural oscillations and mismatch negativity, as well as habituation and pre-pulse inhibition of startle. We outline robust evidence of disrupted sensory processing in individuals with ASD and FXS, and in respective animal models, focusing on the auditory sensory domain. Animal models provide an excellent opportunity to examine common mechanisms of sensory pathophysiology in order to develop therapeutics

Mg II h + k emission lines as stellar activity indicators of main sequence F-K stars

The main purpose of this study is to use the IUE spectra in the analysis of magnetic activity of main sequence F-K stars. Combining IUE observations of MgII and optical spectroscopy of Ca II, the registry of ctivity of stars can be extended in time. We retrieved all the high-resolution spectra of F, G, and K main sequence stars observed by IUE (i.e. 1623 spectra of 259 F to K dwarf stars). We obtained the continuum surface flux near the Mg II h+k lines near 2800 \AA and the MgII line-core surface flux from the IUE spectra. We obtained a relation between the mean continuum flux near the MgII lines with the colour $B-V$ of the star. For a set of 117 nearly simultaneous observations of Mg II and Ca II fluxes of 21 F5 to K3 main sequence stars, we obtained a colour dependent relation between the Mount Wilson CaII S-index and the MgII emission line-core flux. As an application of this calibration, we computed the Mount Wilson index for all the dF to dK stars which have high resolution IUE spectra. For some of the most frequently observed main sequence stars, we analysed the Mount Wilson index S from the IUE spectra, together with the ones derived from visible spectra. We confirm the cyclic chromospheric activity of epsilon Eri (HD 22049) and beta Hydri (HD 2151), and we find a magnetic cycle in alpha Cen B (HD 128621). Complete abstract in the paper.Comment: 10 pages, accepted for publication in Astronomy and Astrophysic

Efficacy of different types of cognitive enhancers for patients with schizophrenia. A meta-analysis

Cognitive impairment is a core feature of schizophrenia, which is predictive for functional outcomes and is, therefore, a treatment target in itself. Yet, literature on efficacy of different pharmaco-therapeutic options is inconsistent. This quantitative review provides an overview of studies that investigated potential cognitive enhancers in schizophrenia. We included pharmacological agents, which target different neurotransmitter systems and evaluated their efficacy on overall cognitive functioning and seven separate cognitive domains. In total, 93 studies with 5630 patients were included. Cognitive enhancers, when combined across all different neurotransmitter systems, which act on a large number of different mechanisms, showed a significant (yet small) positive effect size of 0.10 (k = 51, p = 0.023; 95% CI = 0.01 to 0.18) on overall cognition. Cognitive enhancers were not superior to placebo for separate cognitive domains. When analyzing each neurotransmitter system separately, agents acting predominantly on the glutamatergic system showed a small significant effect on overall cognition (k = 29, Hedges’ g = 0.19, p = 0.01), as well as on working memory (k = 20, Hedges’ g = 0.13, p = 0.04). A sub-analysis of cholinesterase inhibitors (ChEI) showed a small effect on working memory (k = 6, Hedges’ g = 0.26, p = 0.03). Other sub-analyses were positively nonsignificant, which may partly be due to the low number of studies we could include per neurotransmitter system. Overall, this meta-analysis showed few favorable effects of cognitive enhancers for patients with schizophrenia, partly due to lack of power. There is a lack of studies involving agents acting on other than glutamatergic and cholinergic systems, especially of those targeting the dopaminergic system